Search Result

Results for "

3888

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (1) c-Myc (1) Integrin (2) Neurokinin Receptor (1) Reference Standards (1)
By Research Areas:	Cancer (1) Cardiovascular Disease (2) Neurological Disease (1)

Inhibitors & Agonists

Peptides

Natural
Products

Antibodies

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P3888

Gly-Leu-Met-NH2	Neurokinin Receptor	Neurological Disease
Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P (HY-P0201). Substance P is a neuropeptide .

HY-N3888

Excavatin M	Others	Others
Excavatin M is a coumarin-type compound that can be isolated from the chemical constituents of the plant Clausena excavata .

HY-10309

Sibrafiban RO 48-3657	Integrin	Cardiovascular Disease
Sibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregation .

HY-181234

Y502-3888	c-Myc Apoptosis	Cancer
Y502-3888 is a c-Myc inhibitor. Y502-3888 binds to the c-Myc G4 structure, inhibits c-Myc transcription, and downregulates c-Myc expression at both mRNA and protein levels. Y502-3888 inhibits the viability of myeloma cells and induces cell apoptosis. Y502-3888 can be used for the research of multiple myeloma .

HY-10309R

Sibrafiban (Standard) RO 48-3657 (Standard)	Reference Standards Integrin	Cardiovascular Disease
Sibrafiban (Standard) is the analytical standard of Sibrafiban. This product is intended for research and analytical applications. Sibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregation .

Gly-Leu-Met-NH2	Neurokinin Receptor	Neurological Disease
Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P (HY-P0201). Substance P is a neuropeptide .

Excavatin M	Structural Classification Flavonoids Rutaceae Plants Other Flavonoids Clausena excavata N. L. Burman Source Classification	Others
Excavatin M is a coumarin-type compound that can be isolated from the chemical constituents of the plant Clausena excavata .

Host:	Mouse (2) Rabbit (1)
Reactivity:	Human (3) Rat (1) Mouse (1) Monkey (2)
Application:	IHC-P (1) ICC/IF (1) WB (3) FC (2) ELISA (2)
Isotype:	IgG (1) IgG1 (2)
Conjugation:	Non-conjugated (3)
Clonality:	Monoclonal (1) Monoclonal Antibody (1) Recombinant (1)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P84191

	Calretinin Antibody (YA3888) CR; CAL2; CAB29	WB, FC, ELISA	Human, Monkey
	Calretinin Antibody (YA3888) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Calretinin.

HY-P84191A

	Calretinin Antibody (YA3888)(PBS only) CR; CAL2; CAB29	WB, FC, ELISA	Human, Monkey
	Calretinin Antibody (YA3888) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Calretinin.

HY-P81781

	Nuclear Mitotic Apparatus Protein 1 Antibody (YA1526) NMP 22; NUMA; NUMA1; SP H antigen	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	Nuclear Mitotic Apparatus Protein 1 Antibody (YA1526) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Nuclear Mitotic Apparatus Protein 1.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy